Free Trial
OTCMKTS:DMTTF

Small Pharma (DMTTF) Stock Price, News & Analysis

Small Pharma logo
$0.11 0.00 (0.00%)
As of 10/25/2023

About Small Pharma Stock (OTCMKTS:DMTTF)

Key Stats

Today's Range
$0.11
$0.11
50-Day Range
$0.11
$0.11
52-Week Range
$0.05
$0.19
Volume
N/A
Average Volume
113,204 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Small Pharma Inc., a biotechnology company, focuses on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Its clinical program is based on N,N, dimethyltryptamine, a naturally occurring psychoactive molecule. The company's product includes SPL026, which is in clinical Phase IIa for the treatment of major depressive disorder; and SPL028, an injectable formulation of deuterated DMT, which is in Phase 1 clinical trial, as well as SPL801B, an oral dosage. Its preclinical stage programs include SPL029, an oral formulation of a tryptamine to treat depressive disorder. The company is headquartered in London, the United Kingdom.

Receive DMTTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Small Pharma and its competitors with MarketBeat's FREE daily newsletter.

DMTTF Stock News Headlines

Top 5 Small-cap Pharma Stocks in 2025
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
See More Headlines

DMTTF Stock Analysis - Frequently Asked Questions

Small Pharma's stock was trading at $0.1117 at the beginning of 2025. Since then, DMTTF stock has increased by 0.0% and is now trading at $0.1117.
View the best growth stocks for 2025 here
.

Shares of DMTTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:DMTTF
CIK
N/A
Phone
N/A
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (OTCMKTS:DMTTF) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners